How Stomach Stimulation Affects Insulin Levels
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at how a surgically implanted device that stimulates the stomach (called a GES device) affects your body's insulin levels. Researchers will collect blood samples over several hours to understand if and how the device influences insulin production.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have been diagnosed with gastroparesis (a condition where the stomach empties slowly)
- You already have a gastric electrical stimulation (GES) device implanted for at least 3 months
- You are not currently taking insulin injections prescribed for diabetes
- You are willing to have up to 8 blood samples taken (about 5 ml each)
- You are willing to lie in a hospital bed for up to 5.5 hours while the study is conducted
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to program the Enterra stomach pacemaker so it cycles at night, aiming to improve gastroparesis symptoms. It's for people who already have the device and have stable symptoms.
This trial tests a new way to program an implanted device (Enterra®) to better treat severe nausea and vomiting caused by gastroparesis. If you have frequent nausea and vomiting despite other treatments, this study might help find a better setting for your device.
This study tests whether placing a small, implanted device that sends gentle electrical pulses to the stomach can improve symptoms of severe gastroparesis—a condition where the stomach empties too slowly. It's for people whose symptoms haven't been controlled with other treatments and are significantly affecting their daily life.
This study records outcomes for people who need a new implanted stomach electrical stimulation device for severe stomach emptying problems (gastroparesis) that haven’t improved with usual treatments. It may help doctors learn which patients benefit most and how to manage the device over time.
This study tests whether a device that sends gentle electrical pulses to the stomach, already implanted for at least 8 weeks, can reduce daily stomach pain in people with gastroparesis. It may help if you have had chronic stomach pain for more than 2 months.
This study tests whether gentle electrical stimulation applied to the ear (called percutaneous electrical nerve field stimulation) can help reduce nausea and vomiting and improve nervous system function in people with diabetes and gastroparesis (delayed stomach emptying). If you have had gastroparesis for at least a year, this might be a non-drug option to help control your symptoms.
Hear when a new Gastroparesis Nondiabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.